Investor search results
708 investors found
🌍 United States📊 early stage🏷 Therapeutics
Popular searches
Rogers Healy
Christian | Husband | 2x Girl Dad | 1x Boy Dad | Multi-Exited Founder | Venture Capitalist | Investor in 170+ Brands | Music Historian 🤘| YPO | Let’s Win!!
132
investments
Mohamed (Sid) Siddeek
Corporate Vice President and Head of NVentures, NVIDIA’s Venture Capital Group
76
investments
Caroline Farah Lembck, MBA, PhD (abd)
American Businesswoman, Investor & Entrepreneur Founder of LemVega Capital®, Puerto Rico’s leading investment firm going global | Featured NasDaq, Forbes | BA at 19 years old | MBA at 20 | PhD started at 20 | CEO at 21
76
investments
Helen Liang, PhD
Founder & Managing Partner of FoundersX Ventures. Board Director. Featured on WSJ and Business Insider. Invited Speaker at TechCrunch. Guest lecturer at Stanford. Nvidia VC Alliance Partner.
75
investments
…
Frequently asked questions about Therapeutics investors in United States
How many Therapeutics early-stage investors are there in United States?
Gritt tracks 699 Therapeutics early-stage investors in United States, of which 413 (59%) have a direct email address available.
How can I contact Therapeutics investors in United States?
Gritt provides direct email addresses for 59% of investors in this list. Once you have an account, you can export the list or use Gritt AI outreach to draft personalised emails that you review and approve, then send from your Gmail.
Are these investors actively investing in United States startups?
Yes — Gritt ranks investors by their investment activity. The investors at the top of this list have made the most investments in Therapeutics companies and are most likely to be actively seeking new deals.
Can I filter by investment stage or industry?
Yes — use the filters on the left to narrow by investment stage (early, mid, late) or industry. You can also filter by last active date to focus on investors who have made deals recently.
Can I export this list of Therapeutics investors in United States?
Yes — paid Gritt accounts can export any filtered investor list as a CSV, including names, email addresses, LinkedIn profiles and investment counts.
Contact all 699 Therapeutics early-stage investors
Gritt drafts a personalised AI email for each — written from your pitch; you approve each one, then it sends from your Gmail.
Start free — contact these investors